Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
BackgroundValidity is the ability of an instrument to measure what it claims to measure. It means the degree to which the empirical evidence supports the trustworthiness of interpretations based on the calculated scores. The hematological malignancy (HM) specific patient reported outcome measure (HM...
Saved in:
Main Authors: | Pushpendra Goswami (Author), Esther N. Oliva (Author), Tatyana Ionova (Author), Roger Else (Author), Jonathan Kell (Author), Adele K. Fielding (Author), Daniel M. Jennings (Author), Marina Karakantza (Author), Saad Al-Ismail (Author), Graham P. Collins (Author), Stewart McConnell (Author), Catherine Langton (Author), Magda J. Al-Obaidi (Author), Metod Oblak (Author), Sam Salek (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
by: Pushpendra Goswami, et al.
Published: (2020) -
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
by: Pushpendra Goswami, et al.
Published: (2020) -
ADEGAN KALIMAH LANGSUNGDINA NOVEL NGANTEURKEUNKARANGAN USEP ROMLI HM
by: Yuniarti, -
Published: (2007) -
PENGARUH PERPUTARAN PERSEDIAAN TERHADAPRENTABILITAS USAHA PADA PT. HM SAMPOERNA, TBK
by: Firmansyah Furdani, -
Published: (2009) -
Human milk sampling should be standardized if the adequacy of HM nutrients intake is assessed
by: Agnieszka Bzikowska‐Jura
Published: (2022)